Clinical trial
Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and…
NCT00343785 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00343785 |
|---|---|
| Title | Cyclophosphamide and Anti-thymocyte Globulin Followed By Methotrexate and Cyclosporine in Preventing Chronic Graft-Versus-Host Disease in Patients With Severe Aplastic Anemia Undergoing Donor Bone Marrow Transplant |
| Official title | Cyclophosphamide and Antithymocyte Globulin Conditioning Regimen for Marrow Transplantation From HLA-Matched Family Members for Severe Aplastic Anemia: Effect of Marrow Cell Dose on Chronic Graft-vs.-Host Disease: A Multi-Center Trial |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Collaborators | National Heart, Lung, and Blood Institute (NHLBI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Aplastic Anemia |
| Intervention type | Biological, Drug, Genetic, Other, Procedure |
| Interventions | cyclophosphamide, anti-thymocyte globulin, cyclosporine, allogeneic bone marrow transplantation, methotrexate, DNA analysis, flow cytometry, polymorphism analysis, laboratory biomarker analysis |
| Enrollment | 21 |
| Start date | Feb 1, 2006 |
| Primary completion | May 1, 2012 |
| Completion | Aug 1, 2012 |
| First posted | Jun 23, 2006 |
| Last update posted | Apr 13, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: